During the 2024–2025 biennium, Uruguay achieved a major institutional milestone through the establishment of the Uruguayan Health Surveillance Agency (AVISU) as the national regulatory authority for medicines and health technologies. This development significantly strengthened national stewardship, governance, and regulatory oversight of health products.
Uruguay developed the National Plan for the Elimination of Communicable Diseases 2025–2030, addressing priority conditions including tuberculosis, HIV, syphilis, cervical cancer, Chagas disease, and hepatitis B and C, with a specific focus on the elimination of mother‑to‑child transmission.
During the 2024–2025 biennium, Uruguay consolidated structural advances in mental health planning and governance at the subnational level, in line with the implementation of the Mental Health Law. The country began the national expansion of departmental mental health plans, building on the pilot experience in Río Negro, with implementation planned across all 19 departments.
During the 2024–2025 biennium, Uruguay strengthened its health promotion approach based on healthy environments and community participation by consolidating and expanding the healthy municipalities and communities network as a key platform for local and intersectoral action.
During the 2024–2025 biennium, Uruguay advanced efforts to strengthen preparedness and response to public health emergencies in border areas, within the framework of Mercosur regional cooperation.
| Outcome Indicator | Baseline/Target | Rating |
|---|---|---|
| 01.a. Number of countries and territories that show a reduction of at least 10% in hospitalization for ambulatory care sensitive conditions | Baseline 2019 | Partially achieved |
| 01.b. Number of countries and territories that have implemented strategies to strengthen the response capacity of the first level of care | Target 2025 | Achieved |
| 02.e. Number of countries and territories with capacity to implement and monitor national policies or strategies to improve the health and development of young children that are informed by the WHO/UNICEF framework Nurturing Care for Early Childhood Development | Baseline 2019 | Achieved |
| 03.a. Number of countries and territories with capacity to prevent care dependence | Target 2025 | Achieved |
| 07.a. Number of countries and territories that have reduced the density gap with respect to physicians, nurses, and midwives, achieving at least 25 health workers per 10,000 population in underserved areas, keeping in mind the global target of 44.5 by 2030 | Baseline 2019 | Achieved |
| 07.b. Number of countries that have an interprofessional health team at the first level of care, consistent with their model of care | Target 2025 | Partially achieved |
| 08.b. Number of countries and territories with regulatory systems that reach level 3 under the WHO Global Benchmarking Tool (GBT) | Target 2025 | Not achieved |
| 08.c. Number of countries that increase the number of units of blood available for transfusion per thousand inhabitants (UBAT) by at least 5% per year to reach the target of 30 UBAT | Baseline 2019 | Achieved |
| 08.d. Number of countries and territories that have regulations and oversight that ensure access to quality and safe radiological services | Target 2025 | Achieved |
| 08.f. Number of countries and territories that have implemented institutional frameworks, strategies and/or legal frameworks for the assessment, selection and rational use of medicines and other health technologies including antibiotics | Target 2025 | Achieved |
| 09.b. Number of countries and territories that have reached at least 60% of their capacity to implement the essential public health functions | Target 2025 | Not achieved |
| 10.a. Number of countries and territories that have increased public expenditure on health to at least 6% of GDP | Baseline 2019 | Achieved |
| 10.b. Number of countries and territories that have allocated at least 30% of the public expenditure in health to the first level of care | Target 2025 | Achieved |
| Outcome Indicator | Baseline/Target | Rating |
|---|---|---|
| 04.c. Number of countries and territories with at least 95% coverage of syphilis treatment in pregnant women | Target 2025 | Achieved |
| 04.g. Number of countries and territories reporting at least 95% coverage at the national level of the second dose of measles and rubella containing vaccine (MRCV) | Baseline 2019 | Achieved |
| 04.h. Number of countries and territories reporting at least 95% coverage of 3 doses of diphtheria, pertussis, and tetanus -containing vaccine (DPT3) in 80% of municipalities | Target 2025 | Partially achieved |
| 04.j. Number of countries and territories that have incorporated HPV vaccines in their national vaccination program | Baseline 2019 | Achieved |
| 12.b. Number of countries and territories where the entire endemic (by vector transmission) territory or territorial unit has a domestic infestation index (by the main triatomine vector species or by the substitute vector, as the case may be) of less than or equal to 1% | Baseline 2019 | Achieved |
| 12.c. Number of countries and territories with increased antimicrobial resistance (AMR) surveillance capacity to guide the public health interventions for decreasing the risk and preventing the spread of multidrug-resistant infections through intersectoral action | Baseline 2019 | Achieved |
| 17.a. Number of countries and territories that achieve 90% of viral suppression (viral load <1,000 copies/ml) in persons on antiretroviral therapy (ART) | Target 2025 | Partially achieved |
| 17.c [b]. Interruption of transmission of neglected infectious diseases (NID) in countries, following WHO criteria and guidelines [Chagas Disease] | Baseline 2019 | Achieved |
| 17.c [c]. Interruption of transmission of neglected infectious diseases (NID) in countries, following WHO criteria and guidelines [Dog-mediated human rabies] | Baseline 2019 | Partially achieved |
| 17.d. Number of countries and territories with established capacity and effective processes to eliminate human rabies transmitted by dogs | Baseline 2019 | Achieved |
| Outcome Indicator | Baseline/Target | Rating |
|---|---|---|
| 05.a. Number of countries and territories that achieve the 2025 global NCD target to halt the rise in diabetes assessed by age-standardized prevalence of raised blood glucose/diabetes among adults aged 18+ years | Baseline 2019 | Partially achieved |
| 05.e. Number of countries and territories whose surveillance systems have the capacity to report on key indicators of the Global Monitoring Framework for Noncommunicable Diseases | Baseline 2019 | Achieved |
| 05.f. Number of countries and territories that have tertiary care centers that provide rehabilitation services with multi-disciplinary teams for complex injuries | Target 2025 | Achieved |
| 05.i. Number of countries and territories that have increased the rate of persons receiving treatment interventions (pharmacological, psychosocial, and rehabilitation and aftercare services) for substance use disorders in the health service network | Baseline 2019 | Discrepancy |
| 06.b. Number of countries and territories that provide comprehensive post-rape care services in emergency health services, consistent with WHO guidelines | Target 2025 | Achieved |
| 13.d. Number of countries and territories that have eliminated industrially produced trans fatty acids | Target 2025 | Achieved |
| 15.a. Number of countries and territories with an operational advisory committee or lead agency on road safety that supports the development and/or implementation of a national road safety strategy | Baseline 2019 | Achieved |
| 15.b. Number of countries and territories that have a national or multisectoral plan addressing violence that includes the health system | Baseline 2019 | Achieved |
| Outcome Indicator | Baseline/Target | Rating |
|---|---|---|
| 18.g. Number of countries and territories with capacity to address health in chemical safety (including human health exposure to metals and/or pesticides) | Baseline 2019 | Achieved |
| 18.h. Number of countries and territories with capacity to address the health-related effects of climate change | Baseline 2019 | Achieved |
| Outcome Indicator | Baseline/Target | Rating |
|---|---|---|
| 20.a. Number of countries and territories that implement integrated interoperable information systems for health that include subnational disaggregation | Target 2025 | Achieved |
| 21.a. Number of countries and territories with functional governance for generating and using evidence integrated into health systems | Target 2025 | Achieved |
| 21.b. Number of countries and territories that generate, analyze, and use data and information according to health priorities, disaggregated by geopolitical and demographic strata, as appropriate to the national context | Target 2025 | Achieved |
| 22.a. Number of countries and territories implementing a funded policy, strategy and/or agenda on research and innovation for health | Baseline 2019 | Achieved |
| 22.b. Number of countries and territories that have ethical standards for conducting research with human subjects | Baseline 2019 | Achieved |
| Outcome Indicator | Baseline/Target | Rating |
|---|---|---|
| 23.b. Number of States Parties meeting and sustaining International Health Regulations (IHR) requirements for core capacities | Target 2025 | Achieved |
| 24.a. Number of countries and territories with installed capacity to effectively respond to major epidemics and pandemics | Target 2025 | Achieved |
| Outcome Indicator | Baseline/Target | Rating |
|---|---|---|
| 27.a. Proportion of countries and territories where the national health authority reports satisfaction with PAHO/WHO’s leading role on global and regional health issues | Target 2025 | Achieved |
| 27.b. Number of countries and territories for which there is alignment between the national health policy, strategy, or plan and the outcomes defined in the PAHO Strategic Plan 2020-2025 | Target 2025 | Achieved |
1. Access to comprehensive and quality health services
2. Health throughout the life course
3. Quality care for older people
4. Response capacity for communicable diseases
5. Access to services for NCDs and mental health conditions
6. Response capacity for violence and injuries
7. Health workforce
8. Access to health technologies
9. Strengthened stewardship and governance
10. Increased public health financing
12. Risk factors for communicable diseases
13. Risk factors for noncommunicable diseases
15. Intersectoral response to violence and injuries
17. Elimination of communicable diseases
18. Social and environmental determinants
20. Integrated information systems for health
21. Data, information, knowledge, and evidence
22. Research, ethics, and innovation for health
23. Health emergencies preparedness and risk reduction
24. Epidemic and pandemic prevention and control
27. Leadership and governance
| Output (OPT) Indicator | Baseline/Target | Rating |
|---|---|---|
| 01.1.a. Number of countries and territories with frameworks in place for integrated health service delivery networks (IHSDN) to improve the resolution capacity of the first level of care and integrate priority programs, including NCDs and the elimination agenda | Target 2025 | Achieved |
| 01.2.a. Number of countries and territories implementing strategies and/or plans of action to improve quality of care in health service delivery | Target 2025 | Achieved |
| 02.1.a. Number of countries and territories that are implementing a national plan in alignment with the Plan of Action for Women’s, Children’s, and Adolescents’ Health 2018–2030 | Baseline 2023 | Achieved |
| 02.2.a. Number of countries and territories that measure percentage of women of reproductive age who have their need for family planning satisfied with modern methods, disaggregated by age, race/ethnicity, place of residence, and income level | Target 2025 | Partially achieved |
| 02.2.b. Number of countries and territories that measure percentage of pregnant women who received antenatal care four or more times, disaggregated by age, race/ethnicity, and place of residence | Baseline 2023 | Achieved |
| 02.2.d. Number of countries and territories that conduct periodic developmental assessment as part of their services for children | Baseline 2023 | Achieved |
| 02.2.f. Number of countries and territories developing specific and integrated interventions and/or actions at primary care and/or community level focused on optimizing the health and well-being of men | Target 2025 | Partially achieved |
| 03.1.a. Number of countries and territories that implement comprehensive assessments of older persons at the first level of care | Baseline 2023 | Achieved |
| 07.1.a. Number of countries and territories that are implementing a national policy on human resources for health | Baseline 2023 | Achieved |
| 07.2.a. Number of countries and territories with a norm that defines the capacities and scope of practice of inter-professional teams at the first level of care | Target 2025 | Partially achieved |
| 07.3.a. Number of countries and territories enabled to strengthen health workforce competencies and capacity-building programs through the Virtual Campus for Public Health and other WHO platforms | Baseline 2023 | Achieved |
| 08.1.a. Number of countries and territories with updated national policies and/or strategies on access, quality, and use of medicines and other health technologies | Baseline 2023 | Achieved |
| 08.4.a. Number of countries and territories implementing a national plan to strengthen access to radiological services and radiation safety | Baseline 2023 | Achieved |
| 08.4.b. Number of countries and territories implementing a national plan to strengthen access to pharmaceutical services | Target 2025 | Partially achieved |
| 08.4.c. Number of countries and territories implementing national strategies/mechanisms to improve access, quality, safety, or rational use of blood in their services | Baseline 2023 | Achieved |
| 08.4.d. Number of countries and territories implementing a national plan to strengthen access to transplant services | Baseline 2023 | Achieved |
| 08.7.a. Number of countries and territories with mechanisms for health technology assessment and evidence-based incorporation, selection, management, and rational use of medicines and other health technologies | Baseline 2023 | Achieved |
| 09.3.a. Number of countries and territories implementing regulatory frameworks for the provision and financing of integrated people-centered health services | Baseline 2023 | Achieved |
| Output (OPT) Indicator | Baseline/Target | Rating |
|---|---|---|
| 04.1.a. Number of countries and territories implementing national norms, standards, and tools aligned with PAHO and WHO guidelines on TB, HIV, STIs, and VH, with emphasis on key and vulnerable populations | Baseline 2023 | Achieved |
| 04.3.a. Number of NID-endemic countries and territories that implement PAHO recommendations on integrated interventions to reduce the burden of NIDs through their health systems | Target 2025 | Discrepancy |
| 04.5.a. Number of countries and territories with DPT3 immunization coverage of at least 95% that are implementing strategies to reach unvaccinated and under-vaccinated populations | Baseline 2023 | Partially achieved |
| 12.1.a. Number of countries and territories that have campaigns on antimicrobial resistance and rational use aimed at the general public and at professional sectors | Baseline 2023 | Achieved |
| 12.2.a. Number of countries and territories with active programs to control antimicrobial resistance through scaling up of infection prevention and control and provision of water, sanitation, and hygiene in health facilities | Baseline 2023 | Achieved |
| 12.3.a. Number of countries and territories with an established multisectoral coordinating mechanism to oversee national strategies to combat antimicrobial resistance | Baseline 2023 | Achieved |
| 12.4.a. Number of countries and territories that annually provide laboratory-based data on antimicrobial resistance | Baseline 2023 | Achieved |
| 12.6.a. Number of NID-endemic countries and territories that use the framework of the WHO WASH-NTD strategy as part of their national or subnational approach to tackle NIDs | Target 2025 | Discrepancy |
| 12.8.a. Number of countries and territories that have programs to prevent or mitigate zoonotic diseases and snake/arthropod envenoming | Baseline 2023 | Achieved |
| 12.9.a. Number of countries and territories with integrated territorial actions for prevention, control, and/or surveillance of vector-borne transmission of Trypanosoma cruzi | Baseline 2023 | Achieved |
| 17.2.a. Number of countries and territories implementing PAHO policies and frameworks for diseases targeted for elimination as recommended in the Elimination Initiative | Target 2025 | Achieved |
| 17.4.a. Number of countries and territories with official status as foot-and-mouth disease free, with or without vaccination, in accordance with the timeline and expected results established in the PHEFA Action Plan 2021–2025 | Baseline 2023 | Achieved |
| 17.7.a. Number of endemic countries and territories with screening and diagnosis of Chagas implemented for all newborns of mothers who tested positive for Chagas disease during prenatal care | Baseline 2023 | Achieved |
| 17.8.a. Number of countries and territories implementing plans of action to strengthen prevention, prophylaxis, surveillance, and control for the validation of the elimination of rabies transmitted by dogs | Baseline 2023 | Achieved |
| Output (OPT) Indicator | Baseline/Target | Rating |
|---|---|---|
| 05.4.a. Number of countries and territories that collect, analyze, and report a core set of mental health indicators within the national health information systems | Baseline 2023 | Achieved |
| 06.1.a. Number of countries and territories that have a single emergency care access number with full national coverage | Baseline 2023 | Achieved |
| 06.2.a. Number of countries and territories that are implementing national standard operating procedures, protocols, and/or guidelines for the health system response to violence, aligned with PAHO and WHO guidelines | Baseline 2023 | Achieved |
| 13.1.a. Number of countries and territories implementing population-based policy measures to reduce the harmful use of alcohol in line with PAHO and WHO resolutions | Target 2025 | Achieved |
| 13.1.c. Number of countries and territories implementing policies to reduce salt/sodium consumption in the population | Baseline 2023 | Achieved |
| 13.1.d. Number of countries and territories implementing policies and/or actions to regulate unhealthy food and drink products | Baseline 2023 | Achieved |
| 13.1.e. Number of countries and territories covered by best-practice policies to eliminate industrially produced trans-fatty acids in the food supply | Baseline 2023 | Achieved |
| 13.1.f. Number of Member States that have implemented the four major demand-reduction measures in the WHO Framework Convention on Tobacco Control (FCTC) at the highest level of achievement | Baseline 2023 | Achieved |
| 14.1.a. Number of countries and territories that are implementing national policies consistent with the WHO Global Targets 2025 for maternal, infant, and young child nutrition and the nutrition components of the Sustainable Development Goals | Baseline 2023 | Achieved |
| 15.2.a. Number of countries and territories that have a national multisectoral coalition/task force to prevent and respond to violence that includes the health sector | Baseline 2023 | Achieved |
| 16.2.a. Number of countries and territories with national multisectoral strategies and plans aimed at the prevention of suicide across the life course and addressing its main risk factors and social determinants | Baseline 2023 | Achieved |
| Output (OPT) Indicator | Baseline/Target | Rating |
|---|---|---|
| 18.2.c. Number of countries and territories implementing plans, policies, programs, and/or interventions to reduce health risks associated with outdoor air pollution, following WHO guidelines | Baseline 2023 | Achieved |
| 18.2.d. Number of countries and territories implementing plans, policies, programs, and/or interventions to reduce health risks associated with hazardous chemical exposures, following the WHO Chemicals Road Map, the Minamata Convention, and other chemical-related policies and programs | Target 2025 | Achieved |
| 19.2.a. Number of countries and territories that build capacities of local-level governments to integrate health promotion in their planning | Baseline 2023 | Achieved |
| 19.3.a. Number of countries and territories that have established an intersectoral mechanism at national or subnational and local government levels to address the determinants of health, applying the Health in All Policies approach | Baseline 2023 | Achieved |
| 26.2.a. Number of countries and territories implementing policies, plans, and strategies to advance health equity | Baseline 2023 | Achieved |
| 26.5.a. Number of countries and territories using human rights norms and standards in the formulation and implementation of health-related policies, plans, programs, and legislation | Baseline 2023 | Achieved |
| 26.6.a. Number of countries and territories implementing formal accountability mechanisms for health equity, gender and ethnic equality in health, and human rights | Baseline 2023 | Achieved |
| Output (OPT) Indicator | Baseline/Target | Rating |
|---|---|---|
| 20.1.a. Number of countries and territories that have developed and implemented a plan to strengthen information systems for health based on PAHO’s IS4H maturity assessment model | Baseline 2023 | Achieved |
| 20.2.a. Number of countries and territories implementing an updated plan of action for strengthening the quality and coverage of vital statistics | Baseline 2023 | Achieved |
| 22.1.a. Number of countries and territories with a defined policy framework for research for health, including appropriate funding mechanisms reported to the WHO Global Observatory on Health Research and Development | Target 2025 | Achieved |
| 22.2.a. Number of countries and territories with the national health authority enabled to address ethical issues and establish effective mechanisms for ethics oversight of research | Baseline 2023 | Achieved |
| Output (OPT) Indicator | Baseline/Target | Rating |
|---|---|---|
| 23.1.a. Number of States Parties completing annual reporting on the International Health Regulations (2005) | Baseline 2023 | Achieved |
| 23.2.a. Number of States Parties with national action plans developed for strengthening International Health Regulations (2005) core capacities | Baseline 2023 | Achieved |
| 23.3.a. Number of States Parties that have conducted simulation exercises or after-action review | Target 2025 | Achieved |
| 24.2.a. Number of countries and territories with strategies and/or plans in place to detect and respond to high-threat and emerging pathogens, including emerging zoonotic pathogens | Baseline 2023 | Achieved |
| 24.3.a. Number of countries and territories with access to established expert networks and national laboratory policies to support prediction, detection, prevention, control, and response to high-threat and emerging pathogens, including emerging zoonotic pathogen | Baseline 2023 | Achieved |
| 24.3.b. Number of countries and territories performing regular monitoring/auditing of infection prevention and control practices in referral care facilities | Baseline 2023 | Achieved |
| 24.3.c. Number of countries and territories with operational integrated surveillance systems and pandemic preparedness plans for respiratory viruses, including influenza and COVID-19 | Baseline 2023 | Achieved |
| Output (OPT) Indicator | Baseline/Target | Rating |
|---|---|---|
| 27.1.a. Number of countries and territories with a current Country Cooperation Strategy | Baseline 2023 | Achieved |